Related Experiment Videos

Oral famotidine: a potential treatment for children with autism

L A Linday1

  • 1College of Physicians and Surgeons, St Luke's-Roosevelt Hospital Center, New York, NY 10019, USA.

Medical Hypotheses
|May 1, 1997
PubMed

Insights

Famotidine, a histamine-2 receptor blocker, may help treat autism symptoms. Its effectiveness in schizophrenia suggests potential benefits for social deficits in children with autism.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Developmental Pediatrics

Background:

  • Famotidine is a histamine-2 receptor blocker used for gastrointestinal conditions.
  • It has shown efficacy in alleviating deficit symptoms in adults with schizophrenia.
  • Autism Spectrum Disorder (ASD) is characterized by social interaction and communication deficits.

Purpose of the Study:

  • To explore the potential of famotidine in treating social deficits in children with autism.
  • To hypothesize famotidine's utility based on similarities between schizophrenia and autism deficit symptoms.

Main Methods:

  • Review of existing literature on famotidine's effects.
  • Analysis of neurochemical roles of histamine and H2-receptors.
  • Hypothesis generation based on symptom overlap.

Main Results:

  • Histamine acts as a neurotransmitter in the brain.
  • H2-receptors primarily mediate inhibitory signals.
  • Stimulation of H2-receptors decreases spontaneous activity and exploratory behavior.

Conclusions:

  • Blockade of H2-receptors may reverse inhibitory effects.
  • Famotidine's mechanism suggests potential therapeutic application for autism's social deficits.
  • Further research is warranted to investigate famotidine for childhood autism treatment.

Related Concept Videos